Setbacks in Alzheimer research demand new strategies, not surrender

PLoS Med. 2018 Feb 27;15(2):e1002518. doi: 10.1371/journal.pmed.1002518. eCollection 2018 Feb.

Abstract

In this month's editorial, the PLOS Medicine Editors discuss the challenges of addressing a growing population with Alzheimer disease and dementia amidst disappointing news from the pharmaceutical industry.

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease* / economics
  • Alzheimer Disease* / etiology
  • Alzheimer Disease* / pathology
  • Alzheimer Disease* / therapy
  • Biomedical Research* / methods
  • Biomedical Research* / organization & administration
  • Biomedical Research* / trends
  • Disease Progression
  • Drug Discovery / economics
  • Drug Discovery / methods
  • Drug Discovery / standards
  • Drug Discovery / trends
  • Drug Industry / economics
  • Drug Industry / organization & administration
  • Drug Industry / trends
  • Health Services Needs and Demand* / organization & administration
  • Health Services Needs and Demand* / standards
  • Humans
  • Research Design / trends

Grants and funding

The authors are each paid a salary by the Public Library of Science, and they wrote this editorial during their salaried time.